An investigational drug called lerodalcibep lowered low-density lipoprotein (LDL) cholesterol, or “bad” cholesterol, by 50% or more, a new study showed. The year-long clinical trial included people ...
If an injection goes wrong and medicine winds up in a patient's tissue instead of their bloodstream, those patients are often never told. If an injection goes wrong and medicine winds up in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results